top of page

Lacrimal Gland Tumours

Introduction

Can either be epithelial or non-epithelial, and can also be either benign or malignant.
- Epithelial: 40-55% of all lacrimal masses; 55% benign mixed; 50% malignant
- Malignant epithelial tumours: accounts for 2% of all orbital tumours.
- Most common epithelial orbital cancer = adenoid cystic carcinoma.

Dead Giveaways

Benign:

  • Pleomorphic --> mainly orbital lobe and rarely palpebral. Combined epithelial and mesenchymal cells

  • 55% epithelial lacrimal gland tumours are benign mixed tumours

  • Commonly seen in 2nd to 5th decade (mean ~39y)

  • M>F by 1.5x


Malignant:

  • Adenoid Cystic Carcinoma --> rare but most common lacrimal

  • Symptomatic duration is short <6 - 12 months

  • Around 4th decade

diagnostic features

Pleomorphic Tumour Symptoms:

  • Painless exophthalmos, axial downward globe displacement, diplopia, retinal striations, fullness of upper eyelids and palpable eyelid mass

  • Slowly progressive over 12 or more months.


Adenoid Cystic Carcinoma:

  • Exophthalmos

  • Downward globe

  • Displacement

  • Ptosis

  • Diplopia

  • Orbital pain due to perineural tumour (common)

  • Rapid onset with poor prognosis and causes contiguous erosion of bone

  • High morbidity and mortality

  • Referral for CT scan and biopsy.


Treatment of Adenoid Cystic Carcinoma:

  • excision with adjacent tissue

2025, made by Eric Qin. UNSW. SOVS

bottom of page